These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33088813)

  • 21. The relative effect of monotherapy with 5-alpha reductase inhibitors and minoxidil for female pattern hair loss: A network meta-analysis study.
    Gupta AK; Wang T; Bamimore MA; Talukder M
    J Cosmet Dermatol; 2024 Jan; 23(1):154-160. PubMed ID: 37386777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
    Khandpur S; Suman M; Reddy BS
    J Dermatol; 2002 Aug; 29(8):489-98. PubMed ID: 12227482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing Current Therapeutic Modalities of Androgenic Alopecia: A Literature Review of Clinical Trials.
    Bajoria PS; Dave PA; Rohit RK; Tibrewal C; Modi NS; Gandhi SK; Patel P
    Cureus; 2023 Jul; 15(7):e42768. PubMed ID: 37663989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women.
    Bruce AJ; Pincelli TP; Heckman MG; Desmond CM; Arthurs JR; Diehl NN; Douglass EJ; Bruce CJ; Shapiro SA
    Dermatol Surg; 2020 Jun; 46(6):826-832. PubMed ID: 31574029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Female Androgenetic Alopecia: An Update on Diagnosis and Management.
    Starace M; Orlando G; Alessandrini A; Piraccini BM
    Am J Clin Dermatol; 2020 Feb; 21(1):69-84. PubMed ID: 31677111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
    Manabe M; Tsuboi R; Itami S; Osada SI; Amoh Y; Ito T; Inui S; Ueki R; Ohyama M; Kurata S; Kono T; Saito N; Sato A; Shimomura Y; Nakamura M; Narusawa H; Yamazaki M;
    J Dermatol; 2018 Sep; 45(9):1031-1043. PubMed ID: 29863806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative histological and immunohistochemical study on the effect of platelet rich plasma/minoxidil, alone or in combination, on hair growth in a rat model of androgenic alopecia.
    Elsebay SAG; Nada HF; Sultan NSS; El-Waseef DAEA
    Tissue Cell; 2022 Apr; 75():101726. PubMed ID: 35030343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
    Marotta JC; Patel G; Carvalho M; Blakeney S
    Int J Pharm Compd; 2020; 24(1):69-76. PubMed ID: 32023218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
    Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
    Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of androgenetic alopecia.
    Tosti A; Camacho-Martinez F; Dawber R
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.
    Feldman PR; Gentile P; Piwko C; Motswaledi HM; Gorun S; Pesachov J; Markel M; Silver MI; Brenkel M; Feldman OJ; Kamen CL; Uleryk E; Guevara-Aguirre J; Fiebig KM
    Front Med (Lausanne); 2022; 9():998623. PubMed ID: 36755885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
    Tanglertsampan C
    J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia.
    Sanfilippo E; Friedman A
    J Drugs Dermatol; 2024 Mar; 23(3):136-140. PubMed ID: 38443122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol.
    Van Neste D
    Skin Res Technol; 2020 Jul; 26(4):542-557. PubMed ID: 31957152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil
    Gentile P; Garcovich S
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
    Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
    J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural products for male androgenetic alopecia.
    Gupta AK; Talukder M; Bamimore MA
    Dermatol Ther; 2022 Apr; 35(4):e15323. PubMed ID: 35044013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A bibliometric analysis of alternative drug therapy options in the treatment of androgenetic alopecia.
    Gupta AK; Taylor D; Ravi SP; Wang T; Talukder M
    J Cosmet Dermatol; 2024 Jun; ():. PubMed ID: 38873787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow.
    Kozicka K; Łukasik A; Pastuszczak M; Wojas-Pelc A
    Pol Merkur Lekarski; 2019 Feb; 46(272):80-83. PubMed ID: 30830894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.